FindTrial
Sign In

Radiation Therapy in Treating Patients With Prostate Cancer After Surgery

Radiation Therapy in Treating Patients With Prostate Cancer After Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014926
Enrollment
Unknown
Registered
2018-02-22
Start date
2011-09-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

arm A:66 Gy (2Gy x 33 F)
arm B:72 Gy (2Gy x 36 F)

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. adenocarcinoma of the prostate treated with RP; 2. tumor stage pT3a-4, R1, pN1, GS=8 or PSA>0.1ng/ml; 3. WHO performance status of 0 to 1; 4. aged >18 years.

Exclusion criteria

Exclusion criteria: 1. Presence or history of bone metastases; 2. Prior pelvic radiotherapy; 3. The use of products known to affect PSA levels within 4 weeks prior to start of trial treatment

Design outcomes

Primary

MeasureTime frame
Clinical progression-free survival;—

Secondary

MeasureTime frame
Freedom from biochemical progression;Prostate cancer-specific survival;Overall survival;—

Countries

China

Contacts

Public ContactGAO XIAN SHU

Peking University First Hospital

doctorgaoxs@126.com+86 010 83575240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026